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Mutations  in the Jumonji  AT-rich  interactive  domain  1C (JARID1C/SMCX/KDM5C)  gene,  located  at  Xp11.22,
are  emerging  as  frequent  causes  of  X-linked  intellectual  disability  (XLID).  KDM5C  encodes  for  a member
of  an  ARID  protein  family  that  harbors  conserved  DNA-binding  motifs  and  acts  as  a  histone  H3 lysine  4
demethylase,  suggesting  a  potential  role  in  epigenetic  regulation  during  development,  cell  growth  and
differentiation.  In  this  study,  we  describe  clinical  and genetic  ﬁndings  of  a Brazilian  family  co-segregating
a  novel  nonsense  mutation  (c.2172C  > A) in  exon  15  of  KDM5C  gene  with  the  intellectual  disability  phe-
notype.  The  transition  resulted  in replacement  of  the  normal  cysteine  by  a premature  termination  codonDM5C
istone  demethylase
pigenetics
hromatin remodeling
at  position  724  of  the  protein  (p.Cys724X),  leading  to  reduced  levels  of KDM5C  transcript  probably  due  to
nonsense  mediated  mRNA  decay.  The  clinical  phenotype  of  the  proband,  who  has  two  affected  brothers
and  a mild  cognitively  impaired  mother,  consisted  of  short  stature,  speech  delay,  hyperactivity,  vio-
lent  behavior  and  high  palate,  besides  severe  mental  retardation.  Our  ﬁndings  extend  the  number  of
KDM5C  mutations  implicated  in  XLID  and  highlight  its promise  for understanding  neural  function  and
unexplained  cases  of  XLID.ntellectual disability (ID), formerly known as mental retardation
MR), is characterized by substantial limitations in both intellectual
unctioning and adaptative behavior before the age of 18 years, and
as long been recognized as a common and etiologically hetero-
eneous disorder, affecting 1–3% of the general population [4,12].
ver 10% of ID cases with a Mendelian inheritance pattern have
een assigned to the X chromosome, even though it carries only
bout 4% of all human protein-coding genes, leading to a marked
xcess of hemizygous males with intellectual disability as com-
ared to females [15]. Up to now, more than 90 genes have been
ssociated to X-Linked Intellectual Disability (XLID) [6]. Therefore,
utation frequencies in the majority of them are low, especially
or the non syndromic forms of XLID (NS-XLID), which represent
2/3 of all XLID cases. Consequently, many of the genetic deter-
inants of NS-XLID remain to be elucidated. Mutations that give
ise to NS-XLID are not evenly distributed along the X-chromosome
nd seem to be clustered in regions Xp11, Xp22 and Xq26-q28
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[16]. Genes located at these regions have been shown to encode for
proteins involved in signaling pathways, responsible for regulat-
ing cytoskeleton organization and synaptic efﬁcacy, besides acting
in other essential functions, like chromatin remodeling dynamics
[19].
Conversely to other NS-XLID genes, mutations in Jumonji AT-
rich interactive domain 1C (JARID1C/SMCX/KDM5C;  MIM #300534),
a non-pseudoautosomal brain-expressed gene located at Xp11.22,
have emerged as a potential common cause for XLID. KDM5C con-
tains 26 exons and encodes an ubiquitinous 1560-aa protein that
catalyzes the removal of methyl groups from di- and tri-methylated
lysine 4 on histone H3 lysine 4 (H3K4). It suggests a central tran-
scriptional repressive role for KDM5C in chromatin dynamics and
epigenetic regulation during cell growth, differentiation and devel-
opment [5,9,21,24]. Furthermore, the strongest expression of the
predominant KDM5C transcript was observed in skeletal muscle
[8] and brain, mainly in the hippocampus [23] and a biological role
for this gene in neuronal survival and dendritic development has
been provided [7].
KDM5C  protein is homologous to three other proteins of the
Open access under the Elsevier OA license.human JARID1 family (JARID1A, JARID1B and JARID1C). This fam-
ily shares several evolutionarily conserved domains, including the
catalytic JmjC domain, JmjN domain, Arid/Bright domain, C5HC2
zinc-ﬁnger domain and two plant homeodomains (PHD), a motif
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Fig. 1. Family pedigree showing the segregation of the c.2172C > A in the KDM5C gene. Solid squares represent boys with intellectual disability and circle with a dot represents
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nded  at the ﬁfth month, whose malformed newborn died 24 h after being born. 
hromatograms showing the mutations or wild-type sequences are shown below t
hat binds methyl-lysine residues [5,7]. Recent evidence demon-
trates that KDM5C protein can be post translationally modiﬁed
y ubiquitin in vitro, suggesting that this modiﬁcation is function-
lly relevant for maintaining the proper balance between histone
emethylase and methyltransferase activities [13].
Herein, we describe clinical and genetic ﬁndings from a Brazil-
an family segregating a novel nonsense mutation (c.2172C > A) in
DM5C gene compatible with ID phenotype. The mutation gener-
tes a premature termination codon at position 724 of the protein
p.Cys724X) in the C5HC2 zinger ﬁnger domain, leading to reduc-
ion of KDM5C expression levels.
The Brazilian family described here consists of three affected
rothers and a mild cognitively impaired mother. The propositus
TRP), a 13-year-old boy (year of birth 1996), is the fourth of ﬁve
hildren of a young and unrelated couple. He was born by vaginal
elivery after an uncomplicated pregnancy with no major inter-
urrence during neonatal period (birth weight = 2.54 kg; unknown
ength), except for the fact that he was submitted to photother-
py during the ﬁrst week of life due to jaundice. At the age of
4 months, a general developmental delay was recognized (head
ontrol at 6th month of age; sitting position at 8th month of age;
alking at 24th month of age and ﬁrst words at 24th month of
ge), as well as other features such as failure to thrive, learning
ifﬁculties, aggressive behavior, hyperactivity and regular respi-
atory/urinary infections. Clinical investigation included normal
esults for inborn errors of metabolism, computed tomography (CT)
can and abdominal ultrasonography. Due to an idiopathic familial
istory of intellectual disability, compatible with an X-linked pat-
ern, TRP was referred to the Human Genetics Service of the State
niversity of Rio de Janeiro in 2005. He exhibited a normal 550
and resolution karyotype. Mutations in FMR1, FMR2, MECP2 and
RX genes were subsequently ruled out, as well as, submicroscopic
uplications/deletions across chromosome X (through Multiplex
igation-dependent Probe Ampliﬁcation). At the age of 12 years
nd 6 months, he spoke just some words, without making a sen-
ence and exhibited proportionate short stature (height = 130 cm,
elow 3rd percentile), low weight (28.85 kg, below 3rd percentile),
icrocephaly (head circumference = 51 cm,  below 3rd percentile),
igh palate, slight maxillary hypoplasia and small feet, besides
eing severely mental retarded. Clinical features of two affected males. An arrow indicates the proband (II-4). A diamond represents a pregnancy
dicates KDM5C gene without the mutation. NT, is for ‘not available to be tested’.
ted individuals.
siblings are similar to the proband’s, including severe ID and short
stature (Fig. 1). Both are institutionalized, but biological samples
were available for only one of them.
As a short stature phenotype segregates with ID in the family,
molecular analysis of KDM5C coding sequence and ﬂanking intronic
regions was  performed by standard PCR according to Jensen et al.
[8], followed by bidirectional direct sequencing with the BigDye
Terminator kit on an ABI3100 automated sequencer (Applied
Biosystems, Foster City, USA). We  found a novel c.2172C > A transi-
tion in exon 15 of KDM5C gene, which was  conﬁrmed in a new PCR
from a second DNA sample from the patient. KDM5C sequencing
from available members of the family proved that the truncating
mutation segregates completely with the ID phenotype, since the
variant was present in all genotyped individuals with ID (Fig. 2;
individuals II.2 and II.4) and absent in unaffected males (Fig. 2;
individuals II.3 and II.6).
For KDM5C expression analysis, total RNA was obtained from
whole blood of two affected brothers and two  unaffected brothers
using the RiboPure-Blood kit (Ambion, Austin, TX). The integrity
of the RNA was visualized on ethidium stained agarose gels and
quantiﬁed using a ND-1000 Spectrophotometer (NanoDrop Tech-
nologies, Wilmington, DE). For quantitative RT-PCR, 50 ng total
RNA was reverse transcribed into cDNA in the presence of 1.5 g
random hexamers pdN 6 (Invitrogen, Carlsbad, CA) and 0.33 mM
dNTP in a total volume of 30 l using the Roche (Mannheim,
Germany) First Strand cDNA Synthesis Kit. PCR ampliﬁcations
were performed in triplicates of 25 l reactions in the presence of
SYBR green (Applied Biosystems, Foster City, CA). Quantitations
were performed using the absolute quantiﬁcation setting on an
ABI PRISM 7900HT Sequence Detection System (Applied Biosys-
tems, Foster City, CA) and a standard curve generated by serial
dilution (factor 2) of a control cDNA. The PCR primers contain the
following sequences: KDM5C F: 5′-CATCATGGTGCAAGAAGAGC-
3′; KDM5C R: 5′- ATGTGGGAAAGGCAGACAAG-3′;
GAPDH F: 5′-CCACCCATGGCAAATTCC-3′ and GAPDH R: 5′-
TGGGATTTCCATTGATGACAAG-3′. The institutional Ethics Com-
mittee has approved all procedures and samples from TRP patient
and relatives were obtained after receiving informed consent.
We identiﬁed a novel c.2172C > A transition in exon 15 of KDM5C
gene, which resulted in substitution of the original cysteine by
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DFig. 2. The clinical picture showing the individuals (II-2 an
 premature termination codon at position 724 of the protein
p.Cys724X) in the evolutionarily conserved C5HC2 zinger ﬁnger
omain. The mutation was not present in the latest dbSNP build
32 database and was detected in all available affected brothers
nd their mother, an obligate carrier.
As nonsense mutations in KDM5C have previously been shown
o result in reduced KDM5C mRNA levels [8],  we  test whether the
ovel nonsense c.2172C > A mutation found in the present fam-
ly also affect the KDM5C mRNA level. Therefore, we performed
T-qPCR on RNA extracted from two affected brothers and two
naffected brothers. The two affected brothers both show reduced
evels of KDM5C transcript as compared to the unaffected broth-
rs (Table 1), which strongly suggests that this novel nonsense
utation is implicated in the phenotype observed in the patients.
Within the last ﬁve years, twenty putative ID-related and one
utism-related mutations were described along the KDM5C gene
n peer-reviewed publications, including the one reported in this
tudy. Among them, eight represent variants that lead to prema-
ure termination codons, including nonsense variants, small out-of-
rame deletions/insertions or intronic mutation [1,8,17,18,22]
Table 2). The phenotype variability seen within and between fam-
lies is probably due to the functional severity of the mutations,
he existence of possible compensatory mechanisms by alternative
istone demethylases and to other epigenetic and environmental
odifying factors. Shared features among patients harboring these
runcating mutations include mainly moderate to severe ID and
hort stature. Developmental delay in the language domain present
n our patient has been previously reported in a family, in which
D segregates with a single-nucleotide insertion resulting in a pre-
able 1
ifferential expression of JARID1C transcript between patients and controls.
Individual Expressiona
II:2 (affected) 0.313
II:4 (affected) 0.322
II:3 (unaffected) 0.747
II:6 (unaffected) 0.703
a Normalized against GAPDH expression.) who  presented the c.2172C > A mutation in KDM5C gene.
mature termination codon [17]. Moreover, speech delay has been
also related to JARIDIC missense mutations among patients with ID
[22] or autism [2].  Furthermore, the violent behavior exhibited by
TRP and by other KDM5C mutated patients [8] is consistent with
the higher expression of Jarid1c mRNA in certain brain regions of
rodents, like bed nucleus of stria terminalis [23].
Among the ID-related truncating KDM5C mutations, only those
reported by Jensen et al. [8] (p.R68fsX7, p.Arg694X and p.Trp1288X)
and Rujirabanjerd et al. [17] (p.K1087fs(*)43) were evaluated for
KDM5C expression stability, in addition to that reported in this
study (p.Cys724X). Conversely to p.R68fsX7 and p.K1087fs(*)43
mutations, a signiﬁcant reduction of KDM5C expression was  seen
for p.Arg694X, p.Trp1288X and p.Cys724X (see also Table 2), sug-
gesting that the ID phenotype in the individuals carrying these
mutations resulted from functional loss of KDM5C protein likely
due to nonsense mediated mRNA decay (NMD) [3,20].  This mech-
anism ensures the destruction of transcripts containing premature
termination codons to prevent more harmful consequences for the
cell. As to p.R68fsX7, where a loss of transcription was not observed,
it is possible that the mutation leads to ID phenotype due to severe
loss of essential JARIDIC protein domains or to the production of
an anomalous protein from the alternative use of a methionine
downstream of exon 2 [8].  In case of p.K1087fs(*)43, the prema-
ture termination codon associated with the mutation did not lead to
degradation of the mRNA, probably because the insertion is only 52
nucleotides from the exon 22 to 23 boundary and thus insensitive
or only partially sensitive to NMD  [17].
Nonsense mutations not just impair KDM5C activity, but can
also disturb the functions of its target genes. Recently, a KDM5C
expression proﬁling performed on lymphoblastoid cell lines and
blood from patients with ID-related mutations in KDM5C identi-
ﬁed several deregulated genes, including CMKOR1, KDM5B and the
brain expressed KIAA0469 [9].  Also, a KDM5C complex isolated from
HeLa cells showed additional components as chromatin modiﬁers
(e.g. histone deacetylases HDAC1 and HDAC2, and the histone H3K9
methyltransferase G9a) and the RE-1 silencing transcription fac-
tor (REST) [21]. REST regulates the expression of many neuronal
genes, of which some were already implicated in mental retar-
dation, like brain-derived neurotropic factor (BDNF) [14] and the
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Table 2
Variants found in JARID1C gene that lead to premature stop codons in patients with MR phenotype and their consequences.
Nucleotide change Position Amino acid variation Domain Main clinical characteristics Expression analysis Reference
c.202 203insC Exon 2 p.R68fsX7 Inter domains Severe MR, strabismus, violent
behavior, diastema of teeth
Without reduction
of transcript levels
[8]
c.994C > T Exon 8 p.Arg332X PHD zinc ﬁnger Moderate to severe MR,  short
stature
– [22]
c.1583 + 5G > A Intron 11 p.E468GfsX2 JmjC Severe MR, short stature,
microcephaly, maxillary
hypoplasia, hyperreﬂexia
RT-PCR analysis
and cDNA
sequencing
showed skipping of
exon 11
[1]
c.2080C > T Exon 15 p.Arg694X Inter domains MR,  strabismus, myopia, short
stature
Reduction of
transcript levels
[8]
c.3864G > A Exon 23 p.Trp1288X Inter domains Severe MR, spasticity, epilepsy,
short stature, microcephaly,
cryptorchidism, alopecia areata
Reduction of
transcript level
[8]
c.4441 4442delAG Exon 26 p.R1481GfsX9 C-terminal end Severe MR, short stature,
macrocephaly, hyperreﬂexia,
seizures, high palate
– [1]
c.3258 3259insC Exon 21 p.K1087fs(*)43 C-terminal end Severe MR, short stature,
speech delay,
hyperreﬂexia/spasticity
Without reduction
of transcript levels
[17]
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[c.2172C > A Exon 15 p.Cys724X C5HC2 zinc ﬁng
domain
odium channel gene SCN2A [10]. Furthermore, RNA interference
RNAi)-mediated of KDM5C gene resulted in derepression of SCN2A
nd at least other ﬁve genes distributed into three categories:
ACNA1B and CACNA1H,  encoding calcium channels; SCL6A3 and
LC18A1, encoding monoamine transporters; and SLC6A12, encod-
ng a GABA transporter. All these last six KDM5C target genes
ave been previously implicated in neurological disorders such as
pilepsy, autism or schizophrenia [21]. KDM5C also interacts with
mad3, a DNA-binding transcription factor that mediates the trans-
ormation growth factor- (TGF-) signaling. It suggests a role of
DM5C in tumorigenesis and in silico expression analysis showed
n overexpression of this gene in prostate tumors and seminomas
11]. However, to the best of our knowledge, none of the mentally
andicapped harboring KDM5C mutations manifested any kind of
umors.
In contrast to other XLID genes, KDM5C has been highlighted as
ne of the most commonly mutated, justifying the time consum-
ng evaluation of the whole gene and/or routine KDM5C expression
nalysis, mainly when a short stature phenotype segregates with
D in families with at least two affected male siblings. Furthermore,
he identiﬁcation of novel putatively disease-causing mechanisms
ssociated to KDM5C can bring new clues to unravel the genetic
auses of ID, besides it contributes to the understanding of the
pigenetic network involved in neural function and learning. In
ddition, the perspective of reversing epigenetic marks may  pro-
ide new pharmacological tools for therapeutic intervention.
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